Biomarkers in the Accurate Subclassification of Non-Small-Cell Lung Carcinoma for Targeted Therapy: Issues and Prospects

Osmani, Lais; Li, Qing Kay

doi:10.2217/bmm-2017-0059

Cited by 1 publication

(1 citation statement)

References 14 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the relationship between Notch1 expression and clinicopathological characteristics in small-cell lung cancer, we used t -test to compare the two sets of data. P < 0.05 is considered statistically significant [ 26 ].…”

Section: Notch1 Signaling Pathway Inhibits the Growth Of Small-cell L...mentioning

confidence: 99%

Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma

Zhang

2022

Journal of Healthcare Engineering

View full text Add to dashboard Cite

With the gradual application of big data and other technologies to the medical field, more and more people tend to get online medical services. This article mainly studies the comprehensive diagnostic medical system based on Notch1 signaling pathway to inhibit the growth of small-cell lung carcinoma. In the experiment, we used the rapid thawing method to recover the cells and took the logarithmic growth phase cells for cell passage. We calculated the cell concentration and diluted the cells according to the experimental requirements. According to the standard curve, the corresponding sample protein concentration was calculated; at the same time, the Trizol method was used to extract the total RNA, the NanoDrop8000 spectrophotometer was used to determine the RNA concentration, and the RNA quality was detected by agarose gel electrophoresis. We used immunohistochemical staining to complete the staining of lung cancer cells. Finally, black box testing was used to test the functional modules of the system. Experimental data show that the accuracy rate of data obtained by the system reaches 98%, which greatly facilitates doctors and patients. The results show that the system has good ease of use and reliability and improves the diagnosis and treatment of hospital patients.

show abstract

Section: Notch1 Signaling Pathway Inhibits the Growth Of Small-cell L...mentioning

confidence: 99%

Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma

Zhang

2022

Journal of Healthcare Engineering

View full text Add to dashboard Cite

show abstract

Biomarkers in the Accurate Subclassification of Non-Small-Cell Lung Carcinoma for Targeted Therapy: Issues and Prospects

Cited by 1 publication

References 14 publications

Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma

Comprehensive Diagnostic Medical System Based on Notch1 Signaling Pathway to Inhibit the Growth of Small-Cell Lung Carcinoma

Contact Info

Product

Resources

About